Endoscopy in asymptomatic minidose aspirin consumers

Digestive Diseases and Sciences

Volumn 50, Issue 1, 2005, Pages 78-80

  Niv, Yaron ^a   Battler, Alex ^a,b   Abuksis, Galia ^a   Gal, Eyal ^a   Sapoznikov, Boris ^a   Vilkin, Alex ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aspirin; Erosions; Gastropathy; Nonsteroidal anti inflammatory drugs (NSAIDs); Ulcer

Indexed keywords

ACETYLSALICYLIC ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTECTIVE AGENT; PROTON PUMP INHIBITOR; UREASE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CONSUMER; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG USE; DUODENUM ULCER; DYSPEPSIA; EPIGASTRIC PAIN; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTROENTERITIS; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL SYMPTOM; HEALTH CENTER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LABORATORY TEST; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OPEN STUDY; OUTPATIENT; PATIENT REFERRAL; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; STOMACH EROSION; STOMACH PROTECTION; STOMACH ULCER; UPPER GASTROINTESTINAL TRACT; CHEMICALLY INDUCED DISORDER; DIGESTIVE TRACT ENDOSCOPY; DOSE RESPONSE; DRUG ADMINISTRATION; GASTROINTESTINAL TRACT; INTESTINE MUCOSA; MIDDLE AGED; PATHOLOGY; STOMACH MUCOSA; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DUODENAL ULCER; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL TRACT; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; STOMACH ULCER; VASCULAR DISEASES;

EID: 14544286872     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-1281-1     Document Type: Article

References (16)

1. Cryer B: Nonsteroidal anti-inflammatory drug injury. In Sleisenger & Fordtran, Gastrointestinal and Liver Disease, 7th ed. Philadelphia, W. B. Saunders, 2002; pp 408-130
2. Aspirin Myocardial Infarction Study Research Group: A randomized, controlled trial of aspirin in patients recovered from myocardial infarction. JAMA 243:661-669, 1980
3. Slattery I, Warlow CP, Shorrock CI, et al.: Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin - Analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 37:509-511, 1995
4. Lanas A, Bajador E, Serrano P, et al.: Nitrovasodilators, low dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 348:834-839, 2000
5. Kelly JP, Kaufman DW, Jurgelon JM, et al.: Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 348:1413-1416, 1996
6. Cryer B, Luk G, Feldman M: Effects of very low doses of aspirin on gastric, duodenal and rectal prostaglandins and mucosal injury. Gastroenterology 108:A77, 1995
7. Feldman M, Shewmake K, Cryer B: Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans. Am J Physiol Gastrointest Liver Physiol 279:G1113-G1120, 2000
8. Singh G, Triadafilopoulos G: Epidemiology of NSAID-induced GI complications. J Rheumatol 26 (Suppl 26):18-24, 1999
9. Singh G, Ramey DR: NSAID induced gastrointestinal complications: The ARAMIS perspective. J Rheumatol 25:8-16, 1998
10. Silverstein FE, Graham DY, Senior JR, et al.: Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 123:241-249, 1995
11. Silverstein FE, Faich G, Goldstein JL, et al.: Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. JAMA 284:1247-1255, 2000
12. Bombardier C, Laine L, Reicin A, et al.: Rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 343:1520-1528, 2000
13. Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Ann Intern Med 115:787-796, 1991
14. Rodrigues LAG, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 343:769-772, 1994
15. Yeomans ND, Tullasay Z, Juhasz L: A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 338:719-726, 1998
16. Hawkey CJ, Karrasch JA, Szczepanski L: Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 338:727-734, 1998